JNNP Podcast
By BMJ Group
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by BMJ Group
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 20
Reviews: 0
Episodes: 346
Description
JNNP’s ambition is to publish the most ground-breaking and cutting-edge research from around the world. Encompassing the entire genre of neurological sciences, our focus is on the common disorders (stroke, multiple sclerosis, Parkinson’s disease, epilepsy, peripheral neuropathy, subarachnoid haemorrhage and neuropsychiatry), but with a keen interest in the Gordian knots that present themselves in the field, such as ALS.
| Episode | Date |
|---|---|
|
Nutritional peripheral neuropathies, with Dr. Alexander Rossor
|
Apr 17, 2024 |
|
Distinguishing primary from functional tics
|
Feb 19, 2024 |
|
Nitrous Oxide Abuse
|
Sep 22, 2023 |
|
Brain Fog Demystified
|
Aug 08, 2023 |
|
A roadmap to ALS prevention: strategies and priorities
|
Jun 15, 2023 |
|
MOGAD: Definition, diagnosis and treatment
|
May 15, 2023 |
|
CGRP in migraine: current therapeutics, future implications and potential off-target effects
|
Dec 21, 2021 |
|
Alemtuzumab’s impact on functional and structural integrity of the visual system in MS
|
Nov 17, 2021 |
|
Guidelines for the management of functional speech and communication disorders
|
Sep 27, 2021 |
|
The impact of traumatic brain injury on neurocognitive outcomes in children
|
Aug 31, 2021 |
|
Cerebral Microbleeds: from depiction to interpretation
|
Jul 05, 2021 |
|
Motor functional neurological disease, a decade of progress
|
Jun 25, 2021 |
|
COVID - 19 Vaccination and risk of large vessel arterial stroke
|
Jun 03, 2021 |
|
Drug repurposing for progressive multiple sclerosis
|
Mar 02, 2021 |
|
Isaacs syndrome the crossroads of Neurology, Psychiatry and Immunology
|
Nov 25, 2020 |
|
Apathy, cerebral small vessel disease and future dementia risk
|
Sep 28, 2020 |
|
Performance validity tests - Their role in neuropsychology assessments
|
Sep 14, 2020 |
|
Parkinson’s disease: etiopathogenesis and treatment
|
Aug 18, 2020 |
|
Outcome measurement in functional neurological disorder a systematic review and recommendations
|
Jul 20, 2020 |
|
Clinical profiles of patients with dementia and chronic traumatic encephalopathy
|
Jun 22, 2020 |
|
Visual hallucinations in neurological and ophthalmological disease
|
May 27, 2020 |
|
Primary Lateral Sclerosis: new consensus criteria
|
May 12, 2020 |
|
Neurology in the time of COVID - 19
|
May 04, 2020 |
|
Lithium: a slow burner
|
Apr 20, 2020 |
|
Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia
|
Mar 26, 2020 |
|
Multifocal motor neuropathy: controversies and priorities
|
Mar 05, 2020 |
|
Multiple Systems Atrophy: the nature of the beast revisited
|
Feb 12, 2020 |
|
Employment and MS - a patient’s perspective
|
Jan 15, 2020 |
|
Approaches to Chemotherapy induced peripheral neurotoxicity
|
Dec 02, 2019 |
|
Neural circuitry of anxiety
|
Nov 18, 2019 |
|
Dementia after traumatic brain injury
|
Oct 30, 2019 |
|
Mindfullness in multiple sclerosis
|
Sep 27, 2019 |
|
CIDP an update
|
Sep 11, 2019 |
|
Movement disorders and seizures
|
Aug 15, 2019 |
|
The role of functional neuroimaging in functional neurological disorders
|
Jul 31, 2019 |
|
Emotional processing in functional neurological disorder (FND)
|
Jun 12, 2019 |
|
Can cocoa help with fatigue in MS
|
May 28, 2019 |
|
Neurorehabilitation in chronic stroke
|
May 08, 2019 |
|
The real patient value
|
Apr 18, 2019 |
|
Medical conferences - what do we get out of them?
|
Apr 04, 2019 |
|
Oral immunotherapies in MS a comparison of efficacy.
|
Mar 25, 2019 |
|
Therapeutic trial design in frontotemporal dementias
|
Mar 20, 2019 |
|
Do genes affect age of onset in ALS?
|
Mar 11, 2019 |
|
The lifetime risk of common neurological disorders in the elderly population
|
Feb 18, 2019 |
|
PMA and PLS: are they really restricted phenotypes?
|
Feb 04, 2019 |
|
Statins and the risk of recurrent intracerebral haemorrhage (ICH) – what does the evidence say?
|
Jan 21, 2019 |
|
Functional impairment and improvement
|
Dec 10, 2018 |
|
Can computational models help us understand complex movement disorders?
|
Oct 29, 2018 |
|
Idiopathic intracranial hypertension: guidelines for diagnosis and management
|
Oct 08, 2018 |
|
Nusinersen for SMA
|
Aug 29, 2018 |
|
Expanding clinical spectrums in both Kennedy’s disease and poststroke syndromes
|
Aug 06, 2018 |
|
The use of cannabis in epilepsy, and surgery for tremor
|
Jul 02, 2018 |
|
Epilepsy an evidence update
|
May 31, 2018 |
|
Evolution or revolution? Should we re-think clinical practice?
|
Apr 30, 2018 |
|
The Use of Frankincense Extract In MS
|
Apr 04, 2018 |
|
A new questionnaire to measure quality of life in inflammatory neuropathies
|
Mar 07, 2018 |
|
Marriage and a reduced risk of dementia
|
Feb 28, 2018 |
|
Anti-inflammatory approaches to stroke prevention; monitoring disease progression in ALS
|
Feb 08, 2018 |
|
Nodes and paranodes; alternative treatments in MS
|
Jan 26, 2018 |
|
Pathophysiology of functional neurological disorder
|
Dec 13, 2017 |
|
Is methamphetamine use linked to stroke in young adults?
|
Nov 28, 2017 |
|
Cerebral Amyloid Angiopathy: New Insights For Clinical Practice
|
Nov 08, 2017 |
|
Cortical Influences in ALS
|
Oct 31, 2017 |
|
Intravenous immunoglobulin in CIDP
|
Oct 23, 2017 |
|
Complex inherited neuropathies: a new approach to diagnosis?
|
Oct 18, 2017 |
|
Cerebellum and neurodegeneration; autoantibodies and psychological development in children
|
Sep 04, 2017 |
|
Time Matters - part 2: how the real costs of multiple sclerosis are being concealed
|
Aug 07, 2017 |
|
Survival and cause of death in Multiple Sclerosis
|
Jul 19, 2017 |
|
Time Matters - part 1: delay is “expensive” in all aspects of multiple sclerosis
|
Jul 10, 2017 |
|
Seven tesla MRI In Neurodegenerative Dementias
|
Jun 16, 2017 |
|
Conversational Laughter In Dementia
|
May 05, 2017 |
|
Narrative and Neurology: The Andrew Lees Experiment
|
Apr 06, 2017 |
|
April 2017: deconstructing dilemmas in Amyotrophic Lateral Sclerosis and Guillain-Barré Syndrome
|
Mar 27, 2017 |
|
Zika virus and Guillain-Barré Syndrome: what do we know?
|
Mar 13, 2017 |
|
Immunomodulatory therapy in advanced multiple sclerosis
|
Feb 13, 2017 |
|
The relationship between orthostatic hypotension and cognitive impairment in α-synucleinopathies
|
Nov 30, 2016 |
|
A clinical tool for predicting survival in motor neurone disease
|
Nov 30, 2016 |
|
Latitude and disease severity in Multiple Sclerosis
|
Nov 15, 2016 |
|
Do your kids play rugby? Risks for rugby union players from repeated concussions
|
Nov 07, 2016 |
|
Genetics and the clinical course of multiple sclerosis
|
Oct 18, 2016 |
|
Is it time to focus on the common pathways linking neurodegenerative diseases?
|
Oct 13, 2016 |
|
October 2016 Edition: long-term outcomes after stroke; hereditary and inflammatory neuropathies
|
Sep 22, 2016 |
|
Selective vulnerability in clinical variants of Alzheimer’s Disease
|
Aug 30, 2016 |
|
Smoking: a negative prognostic for survival in motor neurone disease patients
|
Aug 19, 2016 |
|
Review: Amyotrophic Lateral Sclerosis and Motor Neuron Syndromes in Asia
|
Jul 27, 2016 |
|
Automated brain volumetrics in multiple sclerosis, plus migraine and psychiatric co-morbidities
|
Jun 30, 2016 |
|
Coffee consumption and multiple sclerosis
|
Jun 07, 2016 |
|
June Edition: Parkinson’s disease and the rate of ALS progression
|
May 24, 2016 |
|
Sudden Unexpected Death in Epilepsy: basic mechanisms and implications for prevention
|
Apr 08, 2016 |
|
Re-evaluating the treatment of acute optic neuritis
|
Feb 10, 2016 |
|
BNPA 2015: Spatial Neglect
|
Jun 08, 2015 |
|
BNPA 2015: New theories of memory systems and networks
|
Jun 08, 2015 |
|
BNPA 2015: Phantom phenomena
|
Feb 24, 2015 |
|
Clinical neurology: why this still matters in the 21st century
|
Jan 27, 2015 |
|
Imaging outcomes for trials of remyelination in multiple sclerosis
|
Dec 11, 2014 |
|
BNPA 2014: Oxytocin and social cognition
|
Dec 02, 2014 |
|
BNPA 2014: Schizophrenia and cognition
|
Dec 02, 2014 |
|
Advances in epilepsy surgery
|
Nov 27, 2014 |
|
Brain atrophy and disability progression in multiple sclerosis patients
|
Oct 13, 2014 |
|
BNPA 2014: Joint hypermobilty and autonomic hyperactivity
|
Sep 17, 2014 |
|
BNPA 2014: Post-Ictal psychosis
|
Sep 17, 2014 |
|
BNPA 2014: TREM2 variants and risk of dementia
|
Sep 17, 2014 |
|
Neurosurgical procedures for psychiatric illness
|
Sep 17, 2014 |
|
Can stress trigger Parkinson’s? And new criteria for frontotemporal dementia syndromes.
|
Aug 05, 2014 |
|
HIV and multiple sclerosis: beginning to unravel a mystery
|
Jul 02, 2014 |
|
BNPA 2014: Neuropsychiatry of social knowledge and moral motivation
|
Jun 24, 2014 |
|
DBS in essential tremor, and genetic counselling for ALS
|
May 22, 2014 |
|
Mortality and morbidity 15 years after hospital admission with mild head injury
|
Apr 30, 2014 |
|
Informed decision making in MS, and the striatum in neurodegeneration
|
Apr 04, 2014 |
|
BNPA special: Autoimmune encephalitis
|
Mar 14, 2014 |
|
BNPA special: The prospects of a vaccine for Alzheimer’s disease
|
Mar 13, 2014 |
|
An unusual variant of Guillain–Barré syndrome, and dopamine dysregulation syndrome
|
Mar 04, 2014 |
|
BNPA special: Impulse control disorder in Parkinson’s
|
Mar 03, 2014 |
|
Diagnosing and treating functional symptoms
|
Jan 10, 2014 |
|
Solving the case, making the diagnosis: Neurology and detective writing
|
Jan 09, 2014 |
|
Radiation for brain metastases, and the genetics of ischaemic stroke
|
Nov 26, 2013 |
|
Education special: Headache
|
Nov 26, 2013 |
|
Aggressive MS, and disappointment following deep brain stimulation for Parkinson’s
|
Oct 25, 2013 |
|
Vitamin D, sunlight, and MS
|
Oct 15, 2013 |
|
Education special: Neurogenetics update
|
Oct 15, 2013 |
|
Diagnosing and treating neuromyelitis optica
|
Aug 19, 2013 |
|
Diagnosing the dementias
|
Jul 23, 2013 |
|
Anti-GQ1b antibody syndrome, and ALS and language deficits
|
Jul 05, 2013 |
|
Striatal cell transplants for Huntington’s disease: where are we now?
|
Jul 05, 2013 |
|
Education special: MS update
|
Jun 11, 2013 |
|
Education special: Peripheral nerve disease update
|
Jun 11, 2013 |
|
Stem cells in neurology, and enlarged perivascular spaces and intracerebral haemorrhage
|
Jun 11, 2013 |
|
Parkinson’s disease subtypes: lost in translation?
|
May 01, 2013 |
|
The latest on stroke
|
May 01, 2013 |
|
Dopamine agonist withdrawal syndrome
|
May 01, 2013 |
|
BNPA 2013: The impact of epilepsy on cognitive function
|
Feb 18, 2013 |
|
BNPA 2013: Psychedelic drugs, magical thinking and psychosis
|
Feb 18, 2013 |
|
BNPA 2013: Decoding consciousness
|
Feb 18, 2013 |
|
BNPA 2013: Epilepsy, depression and anxiety disorders
|
Feb 18, 2013 |
|
BNPA 2013: Brain networks in human epilepsy
|
Feb 18, 2013 |
|
BNPA 2013: Cellular mechanisms of epilepsy
|
Feb 18, 2013 |
|
BNPA 2013: Autoimmunity and neuropsychiatry
|
Feb 18, 2013 |
|
BNPA 2013: Deep brain stimulation for mental illness
|
Feb 18, 2013 |
|
BNPA 2013: The neural correlates of Freudian “repression” in conversion disorder
|
Feb 18, 2013 |
|
BNPA 2013: Effects of early childhood posterior fossa tumours on IQ
|
Feb 18, 2013 |
|
BNPA 2013: Epilepsy and affective disorders, the role of the subgenual prefrontal cortex
|
Feb 18, 2013 |
|
BNPA 2013: Stress and war, and the limits of neuropsychiatry
|
Feb 18, 2013 |
|
BNPA 2013: Childhood stress and risk for later mental disorder
|
Feb 18, 2013 |
|
BNPA 2013: Inflammation and mental illness
|
Feb 18, 2013 |
|
BNPA 2013: Posttraumatic stress disorder and the brain
|
Feb 18, 2013 |
|
BNPA 2013: Equipped to survive, how comprehensive response to threat enables optimal behaviour
|
Feb 18, 2013 |
|
Discovering Emery-Dreifuss muscular dystrophy, and flavour identification in FTLD
|
Feb 15, 2013 |
|
The future of epilepsy research, assessing hemianopia, measuring sensory nerve action potentials
|
Feb 15, 2013 |
|
The Scheltens scale, disability after head injury, and cannabis for multiple sclerosis
|
Feb 15, 2013 |
|
Early days of the Queen Square brain bank; rating dopaminergic replacement therapy response
|
Feb 15, 2013 |
|
Oliver Sacks’s functional paralysis; progressive multifocal leukoencephalopathy
|
Feb 15, 2013 |
|
Recovery after stroke; malingering after concussion
|
Feb 15, 2013 |
|
The future of glioblastoma therapy
|
Feb 15, 2013 |
|
Neurological symptoms from autoimmune syndromes; movement disorders and OCD; counting strokes
|
Feb 15, 2013 |
|
Idiopathic intracranial hypertension; discovering the neurological effects of critical illness
|
Feb 15, 2013 |
|
Diagnostic criteria for CBS; tractography in ALS fifty years ago; better tests for bvFTD
|
Feb 15, 2013 |
|
Surrogate outcomes; CAA and IH; Angela Vincent looks back
|
Feb 15, 2013 |
|
Cerebral amyloid angiopathy; lifestyle and mortality after stroke; motor output patterns
|
Feb 15, 2013 |
|
The early days of chronic fatigue syndrome research; Clues to functional weakness mechanism
|
Feb 15, 2013 |
|
Diagnosing delirium
|
Feb 15, 2013 |
|
Diagnosing conversion disorder; exercise to prevent falls in Parkinson’s patients
|
Feb 15, 2013 |
|
The natural history of Parkinson’s; the latest on MS and latitude
|
Jan 29, 2013 |
|
Athleticism and ALS; understanding peripherally induced movement disorders
|
Jan 29, 2013 |
|
Thrombolysis for elderly stroke patients; disability with organically-unexplained symptoms
|
Jan 29, 2013 |
|
Finger length ratio and ALS; psychotherapy for dizziness
|
Jan 29, 2013 |
|
Frontotemporal dementia reviewed; temporal orientation and dementia
|
Jan 29, 2013 |
|
Dementia and word knowledge; DBS for Parkinson’s
|
Jan 29, 2013 |
|
Genes, vitamin D and MS; hysteria and hypnosis
|
Jan 29, 2013 |
|
Eye movements in motor neurone disease; work and multiple sclerosis
|
Jan 29, 2013 |
|
October 2010
|
Jan 29, 2013 |
|
Predicting adjustment to an ALS diagnosis
|
Jan 29, 2013 |
|
Microbleeds and abuse in dementia
|
Jan 29, 2013 |
|
Migrane co-morbidities
|
Jan 29, 2013 |
|
The SCAN rule
|
Jan 29, 2013 |
|
Epilepsy and driving; Self awareness in dementia
|
Jan 29, 2013 |
|
Pregnancy and MS
|
Jan 29, 2013 |